Clinical Research
Hyundai Bioscience Positions XAFTY As Potential Ebola And Hantavirus Treatment Following Strong IC50 Findings
Ebola IC50 (0.125μM)—Strong inhibition at less than half the concentration of the clinically-tested COVID-19 (0.28μM). Clinical safety confi...
May 22, 2026 | News
Kivo Launches Headless GxP Architecture To Power AI Native Drug Development Workflows
New open architecture connects AI agents, regulated workflows, and human-authenticated action to Kivo’s GxP-compliant platform. Kivo, the unified do...
May 21, 2026 | News
Agilent And A*STAR’s NATi Partner To Advance Next Generation Oligonucleotide Therapeutics Research
Agilent Technologies Inc. announced a two-year research collaboration agreement with Singapore’s Nucleic Acid Therapeutics Initiative (NA...
May 21, 2026 | News
Thermo Fisher Scientific Expands PPD Laboratory Services Network With New Bioanalytical Facility In Sweden
The state-of-the-art facility enhances support for complex modalities across all phases of drug development Key facts Thermo Fisher opens new bioa...
May 19, 2026 | News
ImmunityBio Secures Exclusive US Rights To Tokyo Strain BCG To Address Chronic Bladder Cancer Treatment Shortage
Positive Phase III readout of National Cancer Institute sponsored SWOG S1602 randomized clinical trial demonstrating non-inferior efficacy of the Tokyo...
May 19, 2026 | News
SN BioScience Inc. Initiates Global Phase 1b/2 Trial Of SNB 101 In Extensive Stage Small Cell Lung Cancer
SN BioScience Inc., a clinical-stage biotechnology company based in South Korea, announced today that it has initiated the first patient dosing in its...
May 18, 2026 | News
Akeso, Inc. Highlights Promising Phase II AML Data For Ligufalimab Combination At EHA 2026
Akeso, Inc. announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) will ...
May 18, 2026 | News
Racura Oncology Receives Positive Safety Review Committee Recommendation To Advance CPACS Trial In Advanced Solid Tumours
Safety Review Committee (SRC) gives Racura Oncology a recommendation to continue the Cardioprotection and Anticancer Synergy (CPACS) study in advanced soli...
May 18, 2026 | News
Corti Launches Global Healthcare AI Startup Program Amid Rising Regulatory Pressure Across Europe And The US
As compliance pressure mounts in every major healthcare AI market, Corti launches its Startup Acceleration Program to help founders clear a €600,000 r...
May 15, 2026 | News
Suzhou Ribo Life Science And Insilico Medicine Forge Strategic Alliance To Accelerate AI Powered siRNA Drug Development
Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico Me...
May 14, 2026 | News
Curocell And ProBio Achieve Korean Milestone With Approval Of Next Generation CAR T Therapy Anbal cel
Next-generation anti-CD19 CAR-T, Anbal-cel (CRC01), approval highlights Korean innovation Given the accelerating global momentum in CAR-T and gene th...
May 13, 2026 | News
Hengrui Pharma And Bristol Myers Squibb Forge $15.2 Billion Strategic Alliance Across Oncology And Immunology
Landmark collaboration leverages complementary capabilities to drive speed in early innovation and help advance medicines for patients worldwide Agreement...
May 13, 2026 | News
ACROBiosystems Expands Global Licensing Access For HEK293 Functional Cell Lines
ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global ...
May 12, 2026 | News
Chance Pharma Advances First NDA Submission In China For Innovative Asthma Therapy CXG87
Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhala...
May 11, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
